S. Mcdonald

Safety of sequential immune checkpoint inhibitors after prior immune therapy

Muhammad Awidi, Natalie Dal’bo, K. Gunturu, 2022, Journal of Cancer Research and Clinical Oncology.

Immune response to COVID‐19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T‐cell response

N. Gray, M. Drayson, R. Sadler, 2021, medRxiv.